Oncology Institute, Inc. - *W EXP 99/99/999 (TOIIW)

CUSIP: 68236X118

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / *W EXP 99/99/999
Total 13F shares
3,388,924
Share change
-326,047
Total reported value
$3,898,776
Price per share
$1.15
Number of holders
13
Value change
-$265,424
Number of buys
2
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 68236X118?
CUSIP 68236X118 identifies TOIIW - Oncology Institute, Inc. - *W EXP 99/99/999 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Oncology Institute, Inc. - *W EXP 99/99/999 (TOIIW) as of Q1 2022

As of 31 Mar 2022, Oncology Institute, Inc. - *W EXP 99/99/999 (TOIIW) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,388,924 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), HIGHBRIDGE CAPITAL MANAGEMENT LLC, Davidson Kempner Capital Management LP, Jefferies Group LLC, DIFESA CAPITAL MANAGEMENT, LP, Union Square Park Capital Management, LLC, Man Group plc, WOLVERINE ASSET MANAGEMENT LLC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, and JPMORGAN CHASE & CO. This page lists 13 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.